Study on Nivolumab in Neuroblastoma
Condition: Recurrent Stage IV High Risk Neuroblastoma Intervention: Drug: Nivolumab Sponsor: Shanghai Children's Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials